Effects of epidermal Langerhans cell's conditioned medium on keratinocytes: a role of Langerhans cells in cholesteatoma.
Langerhans cells (LCs) are known to play an important role in the immunosurveillance system. In this study, as in others, numerous LCs were detected in the epithelial layer of acquired cholesteatoma by immunohistochemical staining. This finding suggests that cell-mediated immune responses are initiated by LCs in cholesteatoma; however, documentation concerning the microenvironment of LCs-keratinocytes in cholesteatoma is limited. Therefore, we investigated the effects of LCs on keratinocytes in vitro. To study these effects it was necessary to isolate and purify LCs. Our present study revealed that good enrichment and a high degree of purity (95%) of LCs could be obtained from neonatal rat skin using the immunomagnetic beads (Dynabeads M-450) sorting technique. These isolated LCs have the biologic activity of LCs, and Langerhans cells' conditioned medium (LCCM) stimulates DNA synthesis in thymocytes. The effect of LCCM on keratinocytes was then studied. We found that (1) LCCM stimulated DNA synthesis in keratinocytes was then studied. We found that (1) LCCM stimulated DNA synthesis in keratinocytes, but not protein synthesis, and (2) LCCM stimulated the incorporation of 3H-putrescine into keratinocytes by the activation of transglutaminase. Transglutaminase is a known marker of terminal differentiation in keratinocytes. By Western blot analysis, we identified a 17-kd immunoreactive mouse interleukin-1 alpha in LCCM. Our results imply that LCs found in cholesteatoma tissue may play an important role in stimulating both hyper-proliferation and cornification of keratinocytes; two characteristic features of cholesteatoma formation. These stimulatory effects may be due to the release of interleukin-1 or other factors by LCs.
Kamide
Y
Y
Department of Otolaryngology, College of Physicians and Surgeons, Columbia University, New York, NY 10032.
Sasaki
H
H
Abramson
M
M
Huang
C C
CC
D000818:Animals; D002478:Cells, Cultured; D002781:Cholesteatoma / Q000473:pathology*; D004432:Ear, Middle / Q000473:pathology* / Q000601:surgery; D004848:Epithelium; D005260:Female; D006801:Humans; D015151:Immunoblotting; D007150:Immunohistochemistry; D007163:Immunosorbent Techniques; D007375:Interleukin-1 / Q000008:administration & dosage* / Q000096:biosynthesis / Q000276:immunology; D015603:Keratinocytes / Q000276:immunology*; D007801:Langerhans Cells / Q000382:microbiology*; D008297:Male
D007375:Interleukin-1